Haemonetics Corporation
HAE
$81.35
$0.600.74%
NYSE
| 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | 09/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.68M | 34.03M | 57.98M | 37.49M | 33.83M |
| Total Depreciation and Amortization | 28.26M | 28.76M | 21.51M | 29.03M | 29.22M |
| Total Amortization of Deferred Charges | -- | -- | 6.70M | -- | -- |
| Total Other Non-Cash Items | 18.29M | 10.09M | -10.63M | 7.78M | 13.14M |
| Change in Net Operating Assets | 26.09M | -55.48M | 40.99M | -30.54M | -27.37M |
| Cash from Operations | 111.32M | 17.40M | 116.56M | 43.77M | 48.82M |
| Capital Expenditure | -34.17M | -3.75M | -15.64M | -1.79M | -16.19M |
| Sale of Property, Plant, and Equipment | 120.00K | 297.00K | 2.45M | 251.00K | 189.00K |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -1.76M |
| Divestitures | -- | -- | 43.29M | -- | -- |
| Other Investing Activities | 3.58M | -29.54M | -12.06M | -15.83M | -5.61M |
| Cash from Investing | -30.47M | -33.00M | 18.04M | -17.37M | -23.37M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -1.56M | -1.56M | -1.56M | -1.56M | 88.20M |
| Issuance of Common Stock | 63.00K | 3.94M | 140.00K | 3.54M | 251.00K |
| Repurchase of Common Stock | -75.01M | -4.78M | -150.00M | -449.00K | -75.04M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -39.00K | -36.00K | -27.00K | -149.00K | -88.21M |
| Cash from Financing | -76.55M | -2.44M | -151.45M | 1.38M | -74.80M |
| Foreign Exchange rate Adjustments | -773.00K | 4.18M | 2.77M | -6.21M | 4.20M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.53M | -13.87M | -14.08M | 21.56M | -45.15M |